Similar Items: A bibliometric analysis of global research trends in adoptive cell therapy for triple negative breast cancer over the past 15 years
- The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
- Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)
- Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer
- An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer
- Engineering of siRNA molecules to silence SphK1 mRNA for therapeutic intervention in triple-negative breast cancer: An In Silico and In Vitro Analysis
- A comprehensive bibliometric analysis of global research trends in extramedullary multiple myeloma from 2000 to 2024